Skip to main content
. 2014 Sep 10;34(5):1273–1292. doi: 10.1148/rg.345140009

Figure 3a.

Figure 3a

(a) Axial 18F florbetapir PET images obtained in a healthy patient demonstrate nonspecific cerebellar and cerebral white matter uptake (arrows) with minimal gray matter activity. (b) Axial 18F florbetapir PET images obtained in a patient with known Alzheimer disease demonstrate normal white matter uptake (arrow) and minimal gray matter uptake in the cerebellum, but marked cerebral gray matter uptake that makes gray matter–white matter differentiation difficult.